- €136.62bn
- €169.76bn
- €77.77bn
- 94
- 43
- 97
- 93
R2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 58,483 | 55,254 | 62,265 | 71,977 | 77,769 |
Cost of Revenue | |||||
Gross Profit | 21,634 | 19,888 | 22,738 | 25,847 | 29,653 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52,305 | 50,416 | 55,752 | 62,951 | 68,301 |
Operating Profit | 6,178 | 4,838 | 6,513 | 9,026 | 9,468 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6,933 | 5,502 | 7,496 | 7,154 | 11,201 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,158 | 4,156 | 5,635 | 4,413 | 8,514 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5,174 | 4,030 | 6,160 | 3,723 | 7,950 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5,174 | 4,030 | 6,161 | 3,723 | 7,949 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.08 | 5.44 | 6.61 | 4.44 | 10.5 |
Dividends per Share |